Investegate |Heidelberg Pharma AG Announcements | Heidelberg Pharma AG: Heidelberg Pharma and Chiome Bioscience Sign Exclusive, Target-Specific Research and Option Agreement for the Development of an Antibody Drug Conjugate
Investegate announcements from Heidelberg Pharma AG, Heidelberg Pharma and Chiome Bioscience Sign Exclusive, Target-Specific Research and Option Agreement for the Development of an Antibody Drug Conjugate
Sylvia Wimmer Chiome Bioscience Heidelberg Pharma Amanitin Heidelberg Pharma Mc Services Agreement For The Development
Source: investegate.co.uk